ArticleScientific reports2026
Retention in care and viral suppression in people living with HIV and chronic hepatitis B in Maputo City, Mozambique: a prospective cohort study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Early antiretroviral treatment (ART) has reduced mortality among people living with HIV (PLHIV), but outcomes for HIV-HBV coinfected people in Sub-Saharan Africa remain poorly understood. This study evaluated the impact of HBV coinfection on 12-month retention in care, attrition, mortality, lost to follow-up (LTFU) and viral suppression among PLHIV. This prospective cohort study enrolled newly diagnosed, ART-naïve PLHIV at Mavalane Health Center, Maputo City, from May 2021 to November 2022 and followed participants for 12 months with multiple visits. Monthly cumulative retention, attrition, mortality, and LTFU were calculated; viral suppression was assessed at 6 and 12 months. Associations between baseline characteristics and time-to-event outcomes (attrition, mortality, and LTFU) were evaluated using Cox proportional hazards models. A total of 1,106 participants were enrolled in the study, of whom 81 (7.3%) were HBsAg-positive. Median age was 34.0 years (IQR: 28.0-42.0), and 593 (54.6%) were female. Among the participants, 17.3% of monoinfected and 22.2% of coinfected had a CD4
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.